Assessment of disease activity and damage in SLE: Are we there yet?

C Cruciani, M Zen, M Gatto, E Morand… - Best Practice & Research …, 2023 - Elsevier
Abstract Systemic Lupus Erythematosus is a systemic autoimmune disease characterized by
a great heterogenicity in course and clinical manifestations. Although prognosis improved in …
被引用次数：3 相关文章

Assessment of disease activity and damage in SLE: Are we there yet?

C Cruciani, M Zen, M Gatto, E Morand… - … BEST PRACTICE & …, 2023 - research.unipd.it
: Systemic Lupus Erythematosus is a systemic autoimmune disease characterized by a great
heterogenicity in course and clinical manifestations. Although prognosis improved in the last …

Assessment of disease activity and damage in SLE: Are we there yet?

C Cruciani, M Zen, M Gatto, E Morand… - … BEST PRACTICE & …, 2023 - iris.unito.it
: Systemic Lupus Erythematosus is a systemic autoimmune disease characterized by a great
heterogenicity in course and clinical manifestations. Although prognosis improved in the last …

Assessment of disease activity and damage in SLE: Are we there yet?

C Cruciani, M Zen, M Gatto, E Morand… - Best Practice & research …, 2023 - europepmc.org
Systemic Lupus Erythematosus is a systemic autoimmune disease characterized by a great
heterogenicity in course and clinical manifestations. Although prognosis improved in the last …

Assessment of disease activity and damage in SLE: Are we there yet?

C Cruciani, M Zen, M Gatto, E Morand… - Best practice & … - pubmed.ncbi.nlm.nih.gov
Systemic Lupus Erythematosus is a systemic autoimmune disease characterized by a great
heterogenicity in course and clinical manifestations. Although prognosis improved in the last …